15 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MODIFICATION TO SYNTHES (USA) POLYPIN

FDA 510(k)
FDA Class 2 ·Orthopedic

Premier Explorers

FDA UDI
PREMIER DENTAL PRODUCTS COMPANY·00348783006025·CAVITY FINDER DE 3CH

Alpha-Tec Systems

FDA UDI
Alpha-TEC Systems, Inc.·00816085020778·Auramine O Stain 250ml bottle

Lesser Metatarsal Shortening System

FDA UDI
Paragon 28, Inc.·00889795123626·Met Shortening Implant, Slot, 2.7

FOTONA FIDELIS ER: YAG LASER SYSTEM AND ACCESORIES

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

ACCUCLOT DRVVT SCREEN, CATALOG NO. A6094

FDA 510(k)
FDA Class 1 ·Hematology

DIALYZER

FDA Adverse Event
HAEMOTRONIC LTD.·Product code FJI·September 28, 1994

BIO-CORKSCREW SUTURE ANCHOR

FDA Adverse Event
Injury ·ARTHREX, INC.·Product code MAI·February 21, 2007

AUTOSOFT XC

FDA Adverse Event
Malfunction ·UNOMEDICAL A/S·Product code FPA·August 2, 2024

SCREWDRIVER TI5, LENGTH 300MM

FDA Adverse Event
Malfunction ·SYNTHES GMBH·Product code HXX·February 28, 2013

ENDEAVOR RAPID EXCHANGE CORONARY STENT SYSTEM

FDA Adverse Event
Death ·MEDTRONIC CARDIOVASCULAR GALWAY·Product code NIQ·February 22, 2011

ACS HI-TORQUE BALANCE MIDDLEWEIGHT GUIDE WIRE

FDA Adverse Event
Injury ·ABBOTT VASCULAR-CARDIAC THERAPIES·Product code DQX·February 26, 2008

smiths medical portex Venn Reusable Tracheal Tube Introducer, 15Ch x 60cm, REF 14-504-17 and REF 14-504-17JP

FDA Enforcement
Class II ·Ongoing·Smiths Medical ASD, Inc.·December 4, 2024

UUltrasound System 2300, bkActiv w/battery; Model No. 2300-11; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024